p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage
Status:
Unknown status
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This is multicenter, open-label, randomized, active-controled, phase IV study of local direct
intra-tumor injection of rAd-p53 monotherapy, with concurrent chemotherapy , with concurrent
radiotherapy, or combination with surgery for treatment of head and neck malignant tumors in
advanced stage .